<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1885-642X</journal-id>
<journal-title><![CDATA[Pharmacy Practice (Granada)]]></journal-title>
<abbrev-journal-title><![CDATA[Pharmacy Pract (Granada)]]></abbrev-journal-title>
<issn>1885-642X</issn>
<publisher>
<publisher-name><![CDATA[Centro de Investigaciones y Publicaciones Farmacéuticas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1885-642X2020000200019</article-id>
<article-id pub-id-type="doi">10.18549/pharmpract.2020.2.1927</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Community pharmacy and primary health care in Sweden - at a crossroads]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Westerlund]]></surname>
<given-names><![CDATA[Tommy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marklund]]></surname>
<given-names><![CDATA[Bertil]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Malmö University Faculty of Health &amp; Society Department of Biomedical Science]]></institution>
<addr-line><![CDATA[Malmö ]]></addr-line>
<country>Sweden</country>
</aff>
<aff id="A02">
<institution><![CDATA[,University of Gothenburg Sahlgrenska Academy Institute of Medicine]]></institution>
<addr-line><![CDATA[Gothenburg ]]></addr-line>
<country>Sweden</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>18</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1885-642X2020000200019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1885-642X2020000200019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1885-642X2020000200019&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The overall goal of Swedish health care is good health and equitable care for the whole population. The responsibility for health is shared by the central government, the regions, and the municipalities. Primary care accounts for approximately 20 percent of all expenditures on health care. About 16% of all physicians work in primary health. The regions have also employed a large number of clinical pharmacists, usually hospital-based, but many perform a variety of different primary care services, the most common of which is patient medication reviews. Swedish primary health care is at a crossroads facing extensive challenges, due to changes in demography and demanding financial conditions. These changes necessitate large transformations in health services and delivery. Current Government inquiries have primarily focused on two ways to meet the challenges; a shift towards more local care requiring a transfer of resources from hospital care, and a further development of structured digi-physical care, that is both digital (&#8220;online doctors&#8221;) and physical accessibility of care. While primary care at present is undergoing processes of change, community pharmacy has done so during the past decade since the re-regulation of the Swedish pharmacy market. A monopoly was replaced by a competitive system, where five pharmacy chains now share most of the market, a competition that has made community pharmacy very commercialized. A number of different, promising primary care services are being offered, but they are usually delivered on a small scale due to a lack of remuneration and philosophy of providers. Priority is given to sales and fast dispensing of prescriptions, often with a minimum of counseling. Reflecting primary health care, community pharmacy in Sweden is at a crossroads but currently has a golden opportunity to choose a route of collaboration with primary health care in its current transformation into more local and digi-physical care. A major challenge is that primary health care inquires, strategic plans, and national policy documents usually do not include community pharmacy as a partner. Hence, community pharmacy have to be proactive and seize this chance of changes in primary health policy and organization in order to become an important link in the chain of health care delivery, or there is a significant risk that it will predominantly remain a retail business.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Pharmacies]]></kwd>
<kwd lng="en"><![CDATA[Primary Health Care]]></kwd>
<kwd lng="en"><![CDATA[Delivery of Health Care]]></kwd>
<kwd lng="en"><![CDATA[Integrated]]></kwd>
<kwd lng="en"><![CDATA[Ambulatory Care]]></kwd>
<kwd lng="en"><![CDATA[Community Health Services]]></kwd>
<kwd lng="en"><![CDATA[Pharmacists]]></kwd>
<kwd lng="en"><![CDATA[Community Pharmacy Services]]></kwd>
<kwd lng="en"><![CDATA[Professional Practice]]></kwd>
<kwd lng="en"><![CDATA[Sweden]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<source><![CDATA[Health Resource Guide: Sweden. export.gov]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<source><![CDATA[Sveriges Kommuner och Regioner]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Statistics Sweden (SCB)</collab>
<source><![CDATA[System of Health Accounts 2018]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Sveriges Riksdag</collab>
<source><![CDATA[Swedish Health and Medical Services Act]]></source>
<year>1982</year>
<page-range>763</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>The Commonwealth Fund</collab>
<source><![CDATA[International Health Care System Profiles. The Swedish Health Care System]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Socialstyrelsen</collab>
<source><![CDATA[Assessment of supply and demand of licensed health care and dental practiitioners. The National planning support 2019]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Socialstyrelsen</collab>
<source><![CDATA[About open comparisons of health care, 2019]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Swedish Association of Local Authorities and Regions</collab>
<collab>The National Board of Health and Welfare</collab>
<source><![CDATA[Quality and Efficiency in Swedish Health Care. Regional comparisons 2012]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>Regeringskansliet, Socialdepartementet</collab>
<source><![CDATA[The National medicine strategy 2016-18]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Statistics Sweden (SCB)</collab>
<source><![CDATA[The population of Sweden]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Sveriges Kommuner och Regioner</collab>
<source><![CDATA[Agreement on Good and local care 2020]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Government Offices of Sweden</collab>
<article-title xml:lang=""><![CDATA[Good quality, local health care -A primary care reform]]></article-title>
<source><![CDATA[SOU]]></source>
<year>2018</year>
<page-range>39</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<collab>Regeringskansliet</collab>
<article-title xml:lang=""><![CDATA[Good and local care. A reform for a sustainable health care system]]></article-title>
<source><![CDATA[SOU]]></source>
<year>2020</year>
<page-range>19</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<collab>Regeringskansliet</collab>
<article-title xml:lang=""><![CDATA[Digi-physical care choice. Accessible primary health care based on need and continuity]]></article-title>
<source><![CDATA[The patient choice scheme needs to become digi-physical]]></source>
<year></year>
<page-range>35-50</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Socialstyrelsen</collab>
<source><![CDATA[Patient medication reviews in the elderly, prescribed five or more medicines &#8211;a guidance for health care]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Österberg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical pharmacists in local care. Report on pharmacists in home health care]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Region Sörmland ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gröndal]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Positive effects, challenges and development possibilities. Patient medication reviews with pharmacist support in primary health care in Västmanland Region]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<collab>Sveriges Apoteksförening</collab>
<source><![CDATA[Branch report 2019]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<collab>eHälsomyndigheten</collab>
<source><![CDATA[Electronic expert support (EES)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hammar]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lidström]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Petersson]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gustafson]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Eiermann]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential drug-related problems detected by electronic expert support system: physicians' views on clinical relevance]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2015</year>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>941-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>Apoteksgruppen</collab>
<source><![CDATA[Advice and support for you living with COPD]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<source><![CDATA[TNS Sifo och SA Service AB]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<collab>Tandvårds- och Läkemedelsförmånsverket (TLV)</collab>
<source><![CDATA[Pharmaceutical service in community pharmacy]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="">
<collab>The Dental and Pharmaceutical Benefits Agency (TLV)</collab>
<source><![CDATA[Welcome to the TLV]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>Läkemedelsverket</collab>
<source><![CDATA[Pharmacy indicators, a continued development work. Report from the Medical Products Agency]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Westerlund]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bardage]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Barzi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Berggren]]></surname>
<given-names><![CDATA[A-L]]></given-names>
</name>
<name>
<surname><![CDATA[Ring]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bernsten]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Developing patient-oriented quality indicators for Swedish community pharmacy practice &#8211; a government commission]]></source>
<year>2014</year>
<conf-name><![CDATA[ FIP Congress]]></conf-name>
<conf-loc> </conf-loc>
<publisher-loc><![CDATA[Bangkok, Thailand ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<collab>Tandvårds- och Läkemedelsförmånsverket (TLV)</collab>
<source><![CDATA[Indicators aimed at measuring community pharmacy practice]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<collab>Sveriges Farmaceuter</collab>
<source><![CDATA[About The Swedish Pharmacists Association]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="">
<collab>Sveriges Farmaceuter</collab>
<source><![CDATA[Vision and strategic plan until 2025]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<collab>Apotekarsocieteten</collab>
<source><![CDATA[The Swedish Pharmacy Society&#8217;s policy program in the field of pharmaceuticals]]></source>
<year>2019</year>
<publisher-name><![CDATA[Stockholm]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="">
<collab>NEPI. Nätverk för läkemedelsepidemiologi</collab>
<source><![CDATA[About NEPI]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furängen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[NEPI&#8217;s collaboration project]]></source>
<year>2017</year>
<publisher-name><![CDATA[Stockholm]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
